Adenosine-stimulated contraction in nonpregnant guinea pig myometrium does not involve cyclooxygenase. 1993

M E Bradley, and K A Kuenzli, and I L Buxton
Department of Pharmacology, University of Nevada School of Medicine, Reno.

Cyclooxygenase products are thought to mediate adenosine-stimulated contraction of nonpregnant myometrium. We have examined the effects of the cyclooxygenase inhibitors, indomethacin and meclofenamate, upon adenosine-stimulated contractions in isolated, endometrium-free strips of uterine smooth muscle from virgin guinea pigs. Indomethacin (30 microM) had no effect on adenosine-induced contractions; addition of meclofenamate at 30 microM, however, rapidly and reversibly blocked contractions in response to adenosine, yet had no effect upon acetylcholine-stimulated contractions. Application of prostaglandin F2 alpha at a final concentration of 1.1 microM elicited contractions in indomethacin-treated (but not meclofenamate-treated) tissues. The adenosine receptor antagonist, 8-(p-sulfophenyl)theophylline, interfered with adenosine-mediated contractions when present at a final concentration of 100 microM, confirming the presence of extracellular binding sites for the purine on the smooth muscle. Treatment of muscle strips with either of the adenosine uptake blockers, dipyridamole or S-(p-nitrobenzyl)-6-thio-guanosine, resulted in dramatic reductions in adenosine-stimulated contractions, findings consistent with an additional, intracellular site of action of adenosine in uterine smooth muscle. These results suggest that, in contrast to findings in intact strips of whole uterine tissue, cyclooxygenase activity is not required for adenosine-stimulated contraction in isolated myometrium from nonpregnant guinea pig. It also is suggested that the nonsteroidal anti-inflammatory compound, meclofenamate, may interfere with the binding of another (non-cyclooxygenase) product of arachidonic acid metabolism.

UI MeSH Term Description Entries
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D011983 Receptors, Purinergic Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP. Methyladenine Receptors,Purine Receptors,Purinergic Receptor,Purinergic Receptors,Purinoceptors,Purine Receptor,Purinoceptor,Receptors, Methyladenine,Receptors, Purine,Receptor, Purine,Receptor, Purinergic
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D005260 Female Females
D006151 Guanosine A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013872 Thionucleosides Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
D014590 Uterine Contraction Contraction of the UTERINE MUSCLE. Myometrial Contraction,Contraction, Myometrial,Contraction, Uterine,Contractions, Myometrial,Contractions, Uterine,Myometrial Contractions,Uterine Contractions

Related Publications

M E Bradley, and K A Kuenzli, and I L Buxton
April 1985, American journal of obstetrics and gynecology,
M E Bradley, and K A Kuenzli, and I L Buxton
August 1991, The Journal of pharmacology and experimental therapeutics,
M E Bradley, and K A Kuenzli, and I L Buxton
January 2002, Polish journal of pharmacology,
M E Bradley, and K A Kuenzli, and I L Buxton
January 2008, International archives of allergy and immunology,
M E Bradley, and K A Kuenzli, and I L Buxton
January 2010, Canadian journal of physiology and pharmacology,
M E Bradley, and K A Kuenzli, and I L Buxton
November 1991, The American journal of physiology,
M E Bradley, and K A Kuenzli, and I L Buxton
January 1991, The American journal of physiology,
M E Bradley, and K A Kuenzli, and I L Buxton
February 1983, Immunopharmacology,
M E Bradley, and K A Kuenzli, and I L Buxton
March 1974, The Journal of physiology,
M E Bradley, and K A Kuenzli, and I L Buxton
January 1989, Experientia,
Copied contents to your clipboard!